Company Statement w.r.t. U.S. FDA Completes Two cGMP Inspections at Biocon Biologics Insulins Facility in Malaysia
Company Statement w.r.t. U.S. FDA Completes Two cGMP Inspections at Biocon Biologics Insulins Facility in Malaysia
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds